Rector of Kayseri Erciyes University Prof. Dr. Mustafa Çalış, about domestic vaccine studies, said, “The results of Phase-2 were very good. Antibodies of our volunteers in the vaccinated group were 100 percent. Antibodies were formed in all of our volunteers,” he said.
Erciyes University (ERÜ) Rector Mustafa Çalış visited Metin Kösedağ, President of Kayseri Journalists’ Association.
Rector Mustafa Çalış, during his visit, made statements about the local vaccine studies developed by the Vaccine Research and Development Center (ERAGEM) and Good Clinical Practice and Research Center (İKUM) under ERÜ and supported by the Ministry of Health and the Turkish Health Institutes Presidency (TÜSEB). was found.
“ALL OF OUR VOLUNTEERS HAVE ANTIBODY”
Prof. Dr. Stating that the Phase-2 studies were completed in April, Çalış said, “These studies were reported. Phase-2 results were really good. Antibodies of our volunteers in the vaccinated group were 100 percent. In other words, antibodies were formed in all of our vaccinated volunteers. Not only antibodies, but Phase-2 studies. Of course, it is very important that the antibody is 100 percent, but other efficacy parameters are also very good. The next process will be the Phase-3 phase. The phase-3 phase will be coordinated by the Ministry of Health and TÜSEB. Our Minister of Health Fahrettin Koca stated that Phase-3 studies have already started and that our local vaccine can be used in September, “he said.
“PHASE-3 STUDIES WILL BE AT 20-30 CENTER”
Prof. Dr. Çalış, noting that ERU will also take part in Phase-3 studies, said, “We are in constant consultation with the Ministry of Health and TÜSEB. Our professors attend online meetings every 2-3 days. Of course, there will be a larger volunteer. Maybe there will be 20-30 centers. “The Ministry of Health will appreciate him anyway. They will give information on this matter. As Erciyes University, we will be one of those centers. Phase-3 studies will continue in Kayseri.”
DOES TB VACCINE PREVENT COVID-19?